Statement, 31 October 2014
South Centre Views on US Review of Indian IPR Policy
Below is the official submission of the South Centre sent to the US Trade Representative regarding the Super 301 out of cycle review that the USTR is undertaking with regard to the IPR policy and practice of India. In this submission the South Centre has expressed concern about the pressures that the US is exerting on India to change its IPR policy and laws.
It also expressed appreciation of the Indian IPR policy which has been of benefit not only to India but also the developing countries which depend on the supply of generic medicines from India for meeting their health needs.
This submission has been filed to the office of the USTR, which has acknowledged receipt.
This article was tagged: Affordable Medicines, Health, Intellectual Property, Patent, TRIPS
